Literature DB >> 3037212

Gyrase-inhibitors impair caffeine elimination in man.

A H Staib, S Harder, S Mieke, C Beer, W Stille, P Shah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3037212

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN： 0379-0355


× No keyword cloud information.
  13 in total

Review 1.  Quinolone antimicrobial agents: adverse effects and bacterial resistance.

Authors:  J S Wolfson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

2.  Effect of ketoconazole and terbinafine on the pharmacokinetics of caffeine in healthy volunteers.

Authors:  A Wahlländer; G Paumgartner
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 3.  Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J M Henwood; J P Monk
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

4.  No influence of ciprofloxacin on ethanol disposition. A pharmacokinetic-pharmacodynamic interaction study.

Authors:  F Kamali
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

5.  Absence of effect of rufloxacin on theophylline pharmacokinetics in steady state.

Authors:  M Kinzig-Schippers; U Fuhr; M Cesana; C Müller; A H Staib; S Rietbrock; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

Review 6.  Inhibition of drug metabolism by quinolone antibiotics.

Authors:  D J Edwards; S K Bowles; C K Svensson; M J Rybak
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

7.  Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition.

Authors:  G Barnett; J Segura; R de la Torre; M Carbó
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 8.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

9.  Interaction between oral ciprofloxacin and caffeine in normal volunteers.

Authors:  D P Healy; R E Polk; L Kanawati; D T Rock; M L Mooney
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

Review 10.  Pharmacokinetics of ciprofloxacin.

Authors:  T Bergan; A Dalhoff; R Rohwedder
Journal:  Infection       Date:  1988       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.